In a recent announcement, former President Trump unveiled a series of tariffs targeting multiple sectors, including a steep 100% tariff on imported pharmaceuticals, furniture, and heavy trucks. This move, aimed at bolstering domestic production, has raised considerable alarm among investors and industries reliant on imports, especially in the pharmaceutical sector where concerns about rising drug prices are mounting. European drugmakers are cautiously optimistic about evading these tariffs, while U.S. pharmaceutical companies see fluctuations in stock prices as the market reacts. Trump emphasized that tariffs would apply to specific products unless manufacturers set up local plants, exacerbating fears of economic repercussions both domestically and abroad. As the stock market witnessed shifts following the announcement, analysts are monitoring the potential impacts on various industries and consumer prices.